KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Equity Average (2016 - 2025)

Historic Equity Average for West Pharmaceutical Services (WST) over the last 16 years, with Q4 2025 value amounting to $3.1 billion.

  • West Pharmaceutical Services' Equity Average rose 1459.41% to $3.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.1 billion, marking a year-over-year increase of 1459.41%. This contributed to the annual value of $2.9 billion for FY2025, which is 530.26% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' Equity Average stood at $3.1 billion, which was up 1459.41% from $3.0 billion recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Equity Average registered a high of $3.1 billion during Q4 2025, and its lowest value of $1.8 billion during Q1 2021.
  • For the 5-year period, West Pharmaceutical Services' Equity Average averaged around $2.6 billion, with its median value being $2.7 billion (2024).
  • Per our database at Business Quant, West Pharmaceutical Services' Equity Average soared by 2735.78% in 2021 and then crashed by 547.55% in 2024.
  • West Pharmaceutical Services' Equity Average (Quarter) stood at $2.3 billion in 2021, then increased by 13.62% to $2.6 billion in 2022, then increased by 11.51% to $2.9 billion in 2023, then fell by 5.48% to $2.7 billion in 2024, then increased by 14.59% to $3.1 billion in 2025.
  • Its Equity Average was $3.1 billion in Q4 2025, compared to $3.0 billion in Q3 2025 and $2.8 billion in Q2 2025.